RxDoctor Payments Data

Kenneth Kaplan, MD

Otolaryngology · East Brunswick, NJNPI 1376629147

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.4% of the total across 201 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by Optinose US, Inc. at 26.3% of the total. 2025 is the largest year on record at $870, 4.9 times the $178 reported in 2019.

$3,360in general payments, 2019–2025

Across 201 payments — averaging $16.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Optinose US, Inc.$884
  • Sanofi$792
  • Regeneron Healthcare Solutions, Inc.$537
  • GSK$347
  • Kaleo, Inc.$142
  • Novartis$93
  • plus $564 from 19 others

What the payments were for

  • Food & beverage$3,30798%
  • Education$532%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,360 in reported general payments places this provider in the 80th percentile of 232 otolaryngology providers in New Jersey.

See all otolaryngology providers in New Jersey

Medicare billing

Part B allowed, 2024
$324,741
Medicare patients
954
Services billed
2,677

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluticasone Propionate343$5,594
Fluocinolone Acetonide Oil140$5,555
Azelastine Hcl171$5,259
Ipratropium Bromide129$3,767
Famotidine316$3,464
Mometasone Furoate29$2,203
Ofloxacin70$1,787
Cefdinir54$1,086
Methylprednisolone85$524
Pantoprazole Sodium51$458
Clotrimazole16$313
Montelukast Sodium15$198
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav23$177
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip13$153
Prednisone73$147

Paid to pharmacies, not to this prescriber.

Other otolaryngology in East Brunswick

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →